REQUEST A DEMO
Total
USD $0.00
Search more companies

Luye Pharma Group Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Luye Pharma Group Limited Profile Updated: June 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Luye Pharma Group Limited is primarily engaged in the research, development, production, and sales of natural drugs, new formulations and biotechnology products. The Company offers products that cover oncology, cardiovascular, orthopedics, neurology, hepatology, gastroenterology and gynecology. It also distributes active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis. The Company was incorporated in 1994 and is headquartered in Yantai, China.

Headquarters
Unit 3207, 32nd Floor, Citibank Tower, Citibank Plaza, 3 Garden Road, Central, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Luye Pharma Group Limited report to view the information.

Website: http://www.luye.cn

Basic Information
Total Employees:
Purchase the Luye Pharma Group Limited report to view the information.
Outstanding Shares:
Purchase the Luye Pharma Group Limited report to view the information.
Registered Capital:
Purchase the Luye Pharma Group Limited report to view the information.
Financial Auditors:
Purchase the Luye Pharma Group Limited report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
33.42%
Purchase this report to view the information.
14.68%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Chengdu Luye WBL Biopharmaceutical Co.,Ltd. (China)
100%
Luye Pharma (Germany) GmbH (Germany)
100%
Luye Pharma (Singapore) Pte. Ltd. (Singapore)
100%
Company Performance
Financial values in the chart are available after Luye Pharma Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
5.87%
Total operating revenue
6.81%
Operating profit (EBIT)
157.62%
EBITDA
77.29%
Net Profit (Loss) for the Period
201.46%
Total assets
3.42%
Total equity
15.5%
Operating Profit Margin (ROS)
14.7%
Net Profit Margin
9.24%
Return on Equity (ROE)
1.92%
Debt to Equity Ratio
-13.35%
Quick Ratio
0.12%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?